Larry Alleva

1.8

4.2

4.4

Position	Company	Period
Independent Director	Bright Horizons Family Solutions Inc	Sept. 1, 2012 -
Independent Director	Mersana Therapeutics Inc	Sept. 5, 2017 -
Non-Executive Independent Director	Adaptimmune Therapeutics PLC	March 1, 2015 -
Independent Director	TESARO Inc	March 1, 2012 - Jan. 22, 2019
Independent Director	Synlogic Inc	July 1, 2014 - Aug. 28, 2017

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2023-12-01	2023-12-01	Bright Horizons Family Solutions Inc (BFAM)	PrS Proposed sale	85,877 356.23 US$4,788,481	85,877	356.23	US$4,788,481
2023-12-01	2023-12-01	Bright Horizons Family Solutions Inc (BFAM)	S Sale	72,257 +14.5% 134.49 US$3,278,966	72,257 +14.5%	134.49	US$3,278,966
2021-06-03	2021-06-01	Galera Therapeutics Inc (GRTX)	B Purchase	52,892 +36.5% 431.71 US$2,798,016	52,892 +36.5%	431.71	US$2,798,016
2020-11-17	2020-11-13	Galera Therapeutics Inc (GRTX)	B Purchase	2,325 +58.1% 10.22 US$23,771	2,325 +58.1%	10.22	US$23,771
2020-06-11	2020-06-09	Adaptimmune Therapeutics PLC (ADAP)	B Purchase	12,900 +inf% 1.89 US$24,381	12,900 +inf%	1.89	US$24,381
2020-06-03	2020-06-01	Mersana Therapeutics Inc (MRSN)	B Purchase	700 +181.8% 22.94 US$16,058	700 +181.8%	22.94	US$16,058
2020-06-03	2020-06-01	Mersana Therapeutics Inc (MRSN)	B Purchase	385 +inf% 22.97 US$8,843	385 +inf%	22.97	US$8,843
2020-05-21	2020-05-19	Bright Horizons Family Solutions Inc (BFAM)	B Purchase	227 +3.8% 107.95 US$24,505	227 +3.8%	107.95	US$24,505